ARTICLE | Company News
AZ, Mitsubishi Tanabe in diabetic nephropathy deal
August 21, 2014 12:35 AM UTC
AstraZeneca plc (LSE:AZN; NYSE:AZN) and Mitsubishi Tanabe Pharma Corp. (Tokyo:4508) partnered to validate and progress novel targets and small molecules for diabetic nephropathy into the clinic under ...